World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
151
Citations
94131
World Ranking
1112
National Ranking
53

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Joachim Sieper is affiliated with Charité - University Medicine Berlin in Germany. Their work primarily resides within the field of Medicine, with a strong focus on Rheumatology. The subfields of Immunology, Orthopedics and Sports Medicine, Hematology, and Psychiatry and Mental Health also feature in their research profile.

The scientist's research covers a range of topics related to musculoskeletal and autoimmune disorders, with particular attention to spondyloarthritis studies and treatments. Other topics of focus include rheumatoid arthritis research and therapies, psoriasis treatment and pathogenesis, bone and joint diseases, autoimmune and inflammatory disorders, fibromyalgia and chronic fatigue syndrome, as well as systemic lupus erythematosus research.

Frequent co-authors include:

  • Denis Poddubnyy
  • Mikhail Protopopov
  • Fabian Proft
  • Valeria Ríos Rodríguez
  • Hildrun Haibel

The scientist has published extensively in several venues. The most frequent publication outlets include:

  • Annals of the Rheumatic Diseases
  • RMD Open
  • Lara D. Veeken
  • Zeitschrift für Rheumatologie
  • Revue du Rhumatisme

Recent papers by Joachim Sieper include:

  • Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021, RMD Open)
  • Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial (2022, Annals of the Rheumatic Diseases)
  • Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature (2023, Annals of the Rheumatic Diseases)
  • Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021, Arthritis Research & Therapy)
  • Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility (2021, Lara D. Veeken)

Best Publications

  • What low back pain is and why we need to pay attention

    Jan Hartvigsen;Mark J Hancock;Alice Kongsted;Quinette Louw

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    M Rudwaleit;D van der Heijde;R Landewé;J Listing

  • Prevention and treatment of low back pain: evidence, challenges, and promising directions.

    Nadine E Foster;Johannes R Anema;Dan Cherkin;Roger Chou

  • The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

    J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt

  • Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    J Braun;J Brandt;J Listing;A Zink

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Prevalence of spondylarthropathies in HLA‐B27 positive and negative blood donors

    Jürgen Braun;Mathias Bollow;Gerold Remlinger;Ulrich Eggens

  • Low back pain: a call for action

    Rachelle Buchbinder;Maurits van Tulder;Birgitta Öberg;Lucíola Menezes Costa

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

    Dominique Baeten;Joachim Sieper;Jürgen Braun;Xenofon Baraliakos

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

    C Lukas;R Landewé;J Sieper;M Dougados

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    Désirée van der Heijde;Ben Dijkmans;Piet Geusens;Joachim Sieper

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

    M. Rudwaleit;A. G. Jurik;K.-G. A. Hermann;R. Landewé

  • Ankylosing spondylitis: an overview.

    J Sieper;J Braun;M Rudwaleit;A Boonen

  • How to diagnose axial spondyloarthritis early

    M Rudwaleit;D van der Heijde;M A Khan;J Braun

  • The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

    Martin Rudwaleit;Hildrun Haibel;Xenofon Baraliakos;Joachim Listing

Frequent Co-Authors

Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Martin Rudwaleit
Martin Rudwaleit Ghent University
Joachim Listing
Joachim Listing Leibniz Institute for Neurobiology
Xenofon Baraliakos
Xenofon Baraliakos Ruhr University Bochum
Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
Robert Landewé
Robert Landewé University of Amsterdam
Maxime Dougados
Maxime Dougados Hôpital Cochin
Philip J. Mease
Philip J. Mease University of Washington
Filip Van den Bosch
Filip Van den Bosch Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine, a traditional MD isn’t the only route available. The healthcare field offers several in-demand online degrees that cater to a range of career interests, from clinical practice to healthcare administration.

For those looking to advance their nursing credentials, exploring the most affordable online DNP programs can open doors to higher-level leadership and practitioner roles in healthcare. Similarly, pharmacists have flexible learning options—a popular route is finding the cheapest online pharmacy school to pursue their doctorate without the high costs of traditional programs.

Healthcare also relies on skilled professionals behind the scenes. Earning an online RHIT degree program equips you to manage medical records and health information systems, a field growing rapidly with digital healthcare expansion. If you’re interested in administration and data, you may want to learn how much does it cost to become a medical coder—this career can often be started with an affordable online program.

Each of these alternative paths provides practical medical experience and skills, and with online study options, they offer more accessible and affordable ways to build a rewarding healthcare career.

Best Scientists Citing Joachim Sieper

Trending Scientists

Recently Published Articles